vs
Side-by-side financial comparison of Sprout Social, Inc. (SPT) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Sprout Social, Inc. is the larger business by last-quarter revenue ($120.9M vs $70.6M, roughly 1.7× Viridian Therapeutics, Inc.\DE). On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 12.9%). Sprout Social, Inc. produced more free cash flow last quarter ($9.9M vs $-84.7M).
Sprout Social, Inc. is a technology company that runs a social media management platform. A public company headquartered in Chicago, it was founded in 2010 by Justyn Howard, Aaron Rankin, Gil Lara, and Peter Soung.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
SPT vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $120.9M | $70.6M |
| Net Profit | — | $-34.6M |
| Gross Margin | 77.6% | — |
| Operating Margin | -9.0% | -56.7% |
| Net Margin | — | -49.0% |
| Revenue YoY | 12.9% | 81958.1% |
| Net Profit YoY | — | 54.9% |
| EPS (diluted) | $-0.18 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $120.9M | — | ||
| Q3 25 | $115.6M | $70.6M | ||
| Q2 25 | $111.8M | — | ||
| Q1 25 | $109.3M | — | ||
| Q4 24 | $107.1M | — | ||
| Q3 24 | $102.6M | — | ||
| Q2 24 | $99.4M | — | ||
| Q1 24 | $96.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | $-9.4M | $-34.6M | ||
| Q2 25 | $-12.0M | — | ||
| Q1 25 | $-11.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-17.1M | — | ||
| Q2 24 | $-16.9M | — | ||
| Q1 24 | $-13.6M | — |
| Q4 25 | 77.6% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 77.7% | — | ||
| Q1 25 | 77.3% | — | ||
| Q4 24 | 78.1% | — | ||
| Q3 24 | 77.4% | — | ||
| Q2 24 | 77.5% | — | ||
| Q1 24 | 76.8% | — |
| Q4 25 | -9.0% | — | ||
| Q3 25 | -7.9% | -56.7% | ||
| Q2 25 | -11.0% | — | ||
| Q1 25 | -10.2% | — | ||
| Q4 24 | -12.8% | — | ||
| Q3 24 | -16.4% | — | ||
| Q2 24 | -16.6% | — | ||
| Q1 24 | -13.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | -8.1% | -49.0% | ||
| Q2 25 | -10.7% | — | ||
| Q1 25 | -10.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -16.6% | — | ||
| Q2 24 | -17.0% | — | ||
| Q1 24 | -14.0% | — |
| Q4 25 | $-0.18 | — | ||
| Q3 25 | $-0.16 | — | ||
| Q2 25 | $-0.21 | — | ||
| Q1 25 | $-0.19 | — | ||
| Q4 24 | $-0.25 | — | ||
| Q3 24 | $-0.30 | — | ||
| Q2 24 | $-0.30 | — | ||
| Q1 24 | $-0.24 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $95.3M | $490.9M |
| Total DebtLower is stronger | $40.0M | — |
| Stockholders' EquityBook value | $203.4M | $503.0M |
| Total Assets | $523.1M | $577.1M |
| Debt / EquityLower = less leverage | 0.20× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $95.3M | — | ||
| Q3 25 | $90.6M | $490.9M | ||
| Q2 25 | $101.5M | — | ||
| Q1 25 | $100.9M | — | ||
| Q4 24 | $86.4M | — | ||
| Q3 24 | $82.9M | — | ||
| Q2 24 | $80.9M | — | ||
| Q1 24 | $69.2M | — |
| Q4 25 | $40.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $25.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $203.4M | — | ||
| Q3 25 | $194.1M | $503.0M | ||
| Q2 25 | $184.6M | — | ||
| Q1 25 | $175.3M | — | ||
| Q4 24 | $166.6M | — | ||
| Q3 24 | $158.1M | — | ||
| Q2 24 | $152.1M | — | ||
| Q1 24 | $147.3M | — |
| Q4 25 | $523.1M | — | ||
| Q3 25 | $481.4M | $577.1M | ||
| Q2 25 | $422.9M | — | ||
| Q1 25 | $424.7M | — | ||
| Q4 24 | $428.3M | — | ||
| Q3 24 | $388.8M | — | ||
| Q2 24 | $393.6M | — | ||
| Q1 24 | $389.9M | — |
| Q4 25 | 0.20× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.9M | $-84.6M |
| Free Cash FlowOCF − Capex | $9.9M | $-84.7M |
| FCF MarginFCF / Revenue | 8.2% | -120.1% |
| Capex IntensityCapex / Revenue | 0.9% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $39.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.9M | — | ||
| Q3 25 | $9.3M | $-84.6M | ||
| Q2 25 | $5.1M | — | ||
| Q1 25 | $18.1M | — | ||
| Q4 24 | $4.1M | — | ||
| Q3 24 | $9.0M | — | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | $11.2M | — |
| Q4 25 | $9.9M | — | ||
| Q3 25 | $8.5M | $-84.7M | ||
| Q2 25 | $4.2M | — | ||
| Q1 25 | $16.7M | — | ||
| Q4 24 | $3.3M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $1.6M | — | ||
| Q1 24 | $10.1M | — |
| Q4 25 | 8.2% | — | ||
| Q3 25 | 7.4% | -120.1% | ||
| Q2 25 | 3.7% | — | ||
| Q1 25 | 15.3% | — | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | 8.3% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 10.4% | — |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.7% | 0.2% | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 1.1% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
